retrospective immunohistochemical study was conducted using an avidinbiotin complex (ABC) immunoperoxidase method to demonstrate Sarcocystis neurona in histologically suspect cases of equine protozoa1 myeloencephalitis (EPM). Primary antibodies against S. neurona and S. cruzi were utilized for the ABC technique. The findings were compared with those from cases in which the organisms were detected by examination of hematoxylin and eosin (HE)-stained neuronal sections. HE-stained sections detected the presence of the organisms in 20% of the suspect cases; whereas the ABC technique confirmed the presence of S. neurona in 51% and 67% of the cases by S. neurona and S. cruzi antibodies, respectively. A review of clinical case histories showed that 21/47 (45%) of the EPM horses with parasites in the tissue sections had prior treatment with antiprotozoal drugs and/or steroids. Using the test results of S. neurona and S. cruzi as a standard reference, HE test sensitivity based on examination of up to 30 neuronal sections per case was only 25%, and test specificity was 91%.
for the disease is not yet available. Postmortem diagnosis is based on the presence of characteristic histopathologic lesions and on the identification of the etiological agent. 2, 9 However, the detection of the protozoan by histopathology is laborious and often unrewarding 1, 9 In a recent retrospective investigation of horses necropsied at the Laboratory of Large Animal Pathology, New Bolton Center (NBC), Kennett Square, Pennsylvania, over 20% of the cases had neurologic disease. 7 Of these neurologic cases, 34% were considered to have an infectious cause (protozoal, viral, fungal, or bacterial) . Within this group, EPM was the most frequent etiologic diagnosis based on the presence of characteristic microscopic lesions. 2, 4, 9 However, the etiologic agent, S. neurona, 5 was identified in only 14 of the 70 positive cases of EPM. 7 In the present study, we report of the immunohistochemical findings on these 70 histologically suspect cases of EPM.
Materials and methods
Clinical case histories and necropsy reports of 70 cases with lesions histopathologically compatible with EPM that were diagnosed between 1985 and 1989 at the NBC were examined. These records showed that an average of approximately 30 neuronal hematoxylin and eosin (HE)-stained sections were examined per case. Two histologic sections with the presence of S. neurona (determined from the necropsy report) or, in cases where the organisms were not observed, 2 sections with the most severe and extensive morphologic lesions from each of the suspect EPM cases were selected for immunohistochemistry. Consecutive tissue sections from the selected paraffin blocks (2 per horse) were cut at 5 µm and stained by an avidin-biotin complex (ABC) immunoperoxidase method 6 using a streptavidin-HRP kit. a Primary antibodies against S. neurona and S. cruzi were produced in rabbits.
The immunohistochemical staining was performed essentially as previously reported. 8 The slides were heated at 55 C to melt the paraffin, deparaffinized in xylol, hydrated through graded ethanols, and digested with Pronase (2.5 µg/ ml) for 30 min. Slides were then rinsed in 10% Tween in phosphate-buffered saline, and endogenous peroxidase activity was blocked by 3% H 2 O 2 in methanol for 20 min. Slides were then rinsed and treated with 10% normal goat serum for 20 min to reduce nonspecific background staining and then incubated with diluted primary antibody for 60 min at and incubated with biotinylated secondary antibody (goat ratory, Livestock and Poultry Sciences Institute, ARS, USDA, Belts-anti-rabbit) for 30 min and streptavidin peroxidase complex ville, MD 20705-2350 (Davis, Dubey) , and the Department of Vet-for 30 min at room temperature. Sections were stained with erinary Science, University of Kentucky, Lexington, KY 40546-0099 diaminobenzidine as a substrate and were counterstained (Granstrom) .
with Gill's hematoxylin.
Received for publication August 11, 1992. For the preparation of anti-S. neurona serum, merozoites , 1985-1989. of S. neurona were grown in M617 bovine monocytes as previously described. 3 Cells from infected flasks of M617 cells containing intracellular and extracellular merozoites were scraped and inoculated intramuscularly into a New Zealand white specific-pathogen-free young rabbit. No attempt was made to disrupt the cells and to count the zoites. The rabbit was inoculated within 20 min of scraping the cells from the flask. This procedure was used because we did not know how long S. neurona survives outside cells. Twenty-five days later, the same rabbit was boosted with 115,000 S. neurona culturegrown merozoites filtered through a 3-µm filter. Blood was collected from the rabbit 8 days after the booster inoculation, and the serum was stored at -70 C until used. Indirect fluorescent antibody (IFA) tests were performed on rabbit sera using the culture-derived S. neurona merozoites. The rabbit had an IFA titer of 1:1,600. The S. cruzi antiserum was prepared as previously described. 6 Evaluation of the agreement between S. cruzi and S. neurona immunohistochemical test results was done by calculation of kappa values. 10 Evaluation of the accuracy of HE staining for the organisms was done by calculation of test sensitivity and specificity using the combined immunohistochemical results as the standard reference.
Results
During the period under investigation (5 years), there were 2,380 necropsies, and 1,371 (58%) of these cases were horses ( Table 1 ).
With the use of the ABC immunoperoxidase method, protozoa were found in many more sections. Thirty-five cases (5 1%) and 47 cases (67%) were found positive for the organisms by S. neurona and S. cruzi antibodies, respectively (Table 1 ). However, neither of the anti-Sarcocystis antibodies was able to demonstrate the protozoa (presuming that they were present in the sections) in 2 cases that were positive in HEstained sections. Examination of immunohistochemical stains did not indicate that there was any significant correlation between the severity or extent of the lesion and the number of protozoa that were observed in the tissue sections. In the 47 positive cases, the organisms were found both within (67%) and at some distance from (20%) the inflammatory foci. In 6 cases (13%), they were found at both locations ( Figs. 1-3) . Organisms were found either singly or in clusters in the neuropil ( Fig. 1 ) and occasionally were located within the neurons (Fig. 2) . Within a tissue section, the organisms were variably distributed ( Figs. 1-3) . The total numbers of protozoa per section also varied among cases.
Anti-S. cruzi as the primary antibody identified 14/47 cases (30%) with 1 or 2 schizonts, 13/47 cases (28%) with 3-5 schizonts, and 20/47 cases (43%) with ≥ 6 schizonts per tissue section. Intact schizonts were easily identified; however, because of their small size the individual zoites were not as obvious, except when the schizonts had partially ruptured and the zoites were in the vicinity (Fig. 2) .
Anti-S. cruzi was superior to anti-S. neurona antibody and was able to demonstrate the organisms in 47 cases (67%), whereas the anti-S. neurona antibody was able to show the protozoa in 35 cases (5 1%). Comparing the negative results of the two antibodies and in those cases in which only 1 of the 2 antibodies was able to detect the organism, the anti-S. cruzi antibody failed to stain the organisms in 1 case (in 1986), whereas anti-S. neurona failed to stain (presuming that the protozoa were present in the sections) in 13 cases (3, 2, 4, and 4 cases in 1985, 1987, 1988, and 1989 , respectively) ( Table 2 , 3).
There was also some difference in the intensity of staining between the 2 antibodies. Here again, anti-S. cruzi was considered slightly better because the protozoa were more intensely stained than they were with anti-S. neurona. However, with both antibodies, fine structures within the schizonts were discernable on higher magnification. With both antibodies, nonspe- Table 2 . Number of equine cases in which protozoa (Sarcocystis neurona) were identified in tissue sections and the type of previous treatment of horses with equine protozoal myeloencephalitis (EPM) diagnosed at the Laboratory of Large Animal Pathology, 1985 Pathology, -1989 cific staining of a few slender cells, presumed to be melanin-containing cells, around larger blood vessels and in the meninges in some cases was observed.
Case histories indicated that sulphonamides (trimethoprin sulfadiazine or sulfamethazine and pyrimethamine) were the most frequently used therapeutic drugs in suspect cases of EPM. Steroids were used in a few cases, occasionally in combination with the sulphonamides. In 47/70 cases (67%) of EPM, it was possible to detect the causative agents in tissue sections by immunohistochemical technique using anti-S. cruzi antibody ( Table 1, 2) . Of these animals with demonstrable protozoa in neuronal tissues, 21/47 (45%) had received prior treatment consisting of sulphonamides or steroids or both ( Table 2 ). The duration of treatments with sulphonamides differed among cases. Two of the affected horses were treated for 1 day, 8 were treated for 2-6 days, 5 were treated for 8 days, and 2 were treated for 21 days (3 additional horses were treated with only steroids, and 1 horse's detailed treatment records were missing) ( Table 2) . Table 4 . Number of cases of equine protozoal myeloencephalitis identified using anti-Sarcocystis neurona and anti-S. cruzi antibod-identified as positive or negative by the hematoxylin and eosin (HE) ies. method or the avidin-biotin complex (ABC) immunoperoxidase method using anti-Sarcocystis neurona and anti-S. cruzi as primary antibodies.
The results of the examination of HE-stained sections were compared with those of the ABC immunoperoxidase method using the combined test results of S. neurona and S. cruzi as the standard reference (Table 4 ). Positive cases (i.e., those with the organisms) were identified as positive for either S. neurona or S. cruzi, and negative cases were negative for both. HE test sensitivity, defined as the proportion of ABC-positive cases for either S. neurona or S. cruzi that were also positive on HE staining, was only 25%. HE test specificity, defined as the proportion of horses without S. neurona and S. cruzi ABC reactivity that were also negative on HE staining, was 91%.
Discussion
Equine protozoal myeloencephalitis is the most common infectious cause of equine neurologic disease at our laboratory. 7 The etiologic agent of EPM is an apicomplexan protozoan that has been named S. neurona and has recently been cultured in vitro. 5 Antemortem diagnosis of EPM is difficult because a clinical diagnostic test does not yet exist. The diagnosis is, therefore, based on histopathologic lesions and identification of the protozoa. l ,4,9 A previous retrospective study done at the NBC had. shown that the protozoa were detected in 36% of clinically and histopathologically suspect EPM cases when the examination was based on HE-stained sections. 1 However, in only 20% of the cases in the present study was the organism revealed in HE preparations. Although both of these investigations were done at the NBC, the former study 1 was confined to horses that were admitted to the clinic (M. G. Boy, personal communication), whereas the latter study was based on necropsy cases. Our survey found 70 cases in 5 years, whereas the previous investigation identified only 84 cases in 15 years. The identification of greater numbers of EPM cases per year in the latter survey does not appear to be due to the increased incidence of EPM but most likely reflects the source from which the cases were selected. Granstrom and others 6 described an immunohistochemical method to confirm histopathologic diagnoses of EPM in 3 horses that were previously confirmed by examination and localization of the organisms on HE-stained sections. In the present investigation, we utilized a larger sample size (70 suspect EPM cases) to reconfirm that the ABC immunoperoxidase method may be used to verify the findings of HE examination. This method demonstrated the presence of S. neurona in up to 67% of histopathologically suspect EPM cases. Anti-S. cruzi antibodies (67%) detected more cases than did anti-S. neurona antibodies (5 1%). However, both anti-Sarcocystis antibodies may be equally good for the detection of the protozoa. To access the agreement between the S. cruzi and S. neurona tests, a kappa value was calculated (actual agreement beyond chance/potential agreement beyond chance) ( Table 3 ). The moderately high kappa of 0.6 reveals that the agreement between the 2 tests is not merely due to chance. 10 The discrepancy between the results of the 2 immunohistochemical tests is probably due to the fact that the number of protozoa is limited in the affected tissues and that the protozoa are not distributed uniformly in the sections of the affected neuronal tissues. The same reasoning can be extended to the HE findings, where neither of the anti-Sarcocystis antibodies was able to demonstrate the protozoa in 2 cases although they were seen in HE-stained sections. The differences between the S. neurona and S. cruzi tests may be related to different stages of Sarcocystis (merozoites in S. neurona vs. bradyzoites in S. cruzi) and the methods of immunization of the rab-. bit
Treatment of EPM cases with sulphonamides alone or in combination with pyrimethamine has been as-sociated with reduced likelihood of finding S. neurona in CNS tissue sections. 1 However, our results indicate that 21/47 animals (45%) with detectable protozoa in tissue sections had had prior treatment with sulphonamides and/or steroids. This discrepancy between studies could be due to case section or to the fact that the previous study 1 was based on the detection of the protozoa on HE-stained sections whereas our study utilized an immunohistochemical method.
